vs

Side-by-side financial comparison of Cambium Networks Corp (CMBM) and KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS). Click either name above to swap in a different company.

Cambium Networks Corp is the larger business by last-quarter revenue ($40.3M vs $22.6M, roughly 1.8× KESTRA MEDICAL TECHNOLOGIES, LTD.). Cambium Networks Corp runs the higher net margin — -17.9% vs -145.3%, a 127.4% gap on every dollar of revenue. Cambium Networks Corp produced more free cash flow last quarter ($-10.8M vs $-25.6M).

Cambium Networks Corporation is an American manufacturer of wireless telecommunications equipment, including Enterprise WiFi, Network switch, Internet of Things, and fixed wireless broadband and Wi-Fi for enterprises products for Internet access. Publicly traded on the NASDAQ stock exchange, it spun out of Motorola in October 2011.

Kestra Medical Technologies, Ltd. is a medical device firm that develops, manufactures and commercializes innovative minimally invasive therapeutic solutions, mainly for interventional cardiology and structural heart disease treatment. It operates across North America, Europe and key Asia-Pacific markets, serving global healthcare providers and patients.

CMBM vs KMTS — Head-to-Head

Bigger by revenue
CMBM
CMBM
1.8× larger
CMBM
$40.3M
$22.6M
KMTS
Higher net margin
CMBM
CMBM
127.4% more per $
CMBM
-17.9%
-145.3%
KMTS
More free cash flow
CMBM
CMBM
$14.8M more FCF
CMBM
$-10.8M
$-25.6M
KMTS

Income Statement — Q4 FY2024 vs Q2 FY2026

Metric
CMBM
CMBM
KMTS
KMTS
Revenue
$40.3M
$22.6M
Net Profit
$-7.2M
$-32.8M
Gross Margin
36.6%
50.6%
Operating Margin
-28.4%
-140.7%
Net Margin
-17.9%
-145.3%
Revenue YoY
-23.2%
Net Profit YoY
71.0%
EPS (diluted)
$-0.26
$-0.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CMBM
CMBM
KMTS
KMTS
Q4 25
$22.6M
Q3 25
$19.4M
Q4 24
$40.3M
Q3 24
$44.7M
Q2 24
$45.2M
Q1 24
$47.1M
Q4 23
$52.5M
Q3 23
$44.6M
Net Profit
CMBM
CMBM
KMTS
KMTS
Q4 25
$-32.8M
Q3 25
$-25.8M
Q4 24
$-7.2M
Q3 24
$-34.5M
Q2 24
$-14.2M
Q1 24
$-18.4M
Q4 23
$-24.9M
Q3 23
$-36.4M
Gross Margin
CMBM
CMBM
KMTS
KMTS
Q4 25
50.6%
Q3 25
45.7%
Q4 24
36.6%
Q3 24
43.6%
Q2 24
32.5%
Q1 24
29.8%
Q4 23
15.2%
Q3 23
26.7%
Operating Margin
CMBM
CMBM
KMTS
KMTS
Q4 25
-140.7%
Q3 25
-149.1%
Q4 24
-28.4%
Q3 24
-69.6%
Q2 24
-27.2%
Q1 24
-33.1%
Q4 23
-44.5%
Q3 23
-46.2%
Net Margin
CMBM
CMBM
KMTS
KMTS
Q4 25
-145.3%
Q3 25
-133.3%
Q4 24
-17.9%
Q3 24
-77.3%
Q2 24
-31.5%
Q1 24
-39.2%
Q4 23
-47.5%
Q3 23
-81.5%
EPS (diluted)
CMBM
CMBM
KMTS
KMTS
Q4 25
$-0.64
Q3 25
$-0.50
Q4 24
$-0.26
Q3 24
$-1.22
Q2 24
$-0.51
Q1 24
$-0.66
Q4 23
$-0.90
Q3 23
$-1.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CMBM
CMBM
KMTS
KMTS
Cash + ST InvestmentsLiquidity on hand
$175.4M
Total DebtLower is stronger
$67.6M
Stockholders' EquityBook value
$-3.2M
$164.1M
Total Assets
$173.7M
$246.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CMBM
CMBM
KMTS
KMTS
Q4 25
$175.4M
Q3 25
$201.2M
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23
Q3 23
Total Debt
CMBM
CMBM
KMTS
KMTS
Q4 25
Q3 25
Q4 24
$67.6M
Q3 24
$67.6M
Q2 24
$68.9M
Q1 24
$63.8M
Q4 23
$25.1M
Q3 23
$25.8M
Stockholders' Equity
CMBM
CMBM
KMTS
KMTS
Q4 25
$164.1M
Q3 25
$184.2M
Q4 24
$-3.2M
Q3 24
$1.9M
Q2 24
$34.1M
Q1 24
$45.0M
Q4 23
$61.1M
Q3 23
$82.5M
Total Assets
CMBM
CMBM
KMTS
KMTS
Q4 25
$246.7M
Q3 25
$266.3M
Q4 24
$173.7M
Q3 24
$194.3M
Q2 24
$221.1M
Q1 24
$219.8M
Q4 23
$209.1M
Q3 23
$222.4M
Debt / Equity
CMBM
CMBM
KMTS
KMTS
Q4 25
Q3 25
Q4 24
Q3 24
36.12×
Q2 24
2.02×
Q1 24
1.42×
Q4 23
0.41×
Q3 23
0.31×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CMBM
CMBM
KMTS
KMTS
Operating Cash FlowLast quarter
$-10.4M
$-18.3M
Free Cash FlowOCF − Capex
$-10.8M
$-25.6M
FCF MarginFCF / Revenue
-26.8%
-113.5%
Capex IntensityCapex / Revenue
1.1%
32.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-21.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CMBM
CMBM
KMTS
KMTS
Q4 25
$-18.3M
Q3 25
$-26.3M
Q4 24
$-10.4M
Q3 24
$8.9M
Q2 24
$2.4M
Q1 24
$-15.9M
Q4 23
$-5.8M
Q3 23
$-345.0K
Free Cash Flow
CMBM
CMBM
KMTS
KMTS
Q4 25
$-25.6M
Q3 25
$-34.4M
Q4 24
$-10.8M
Q3 24
$6.8M
Q2 24
$87.0K
Q1 24
$-17.4M
Q4 23
$-7.4M
Q3 23
$-1.5M
FCF Margin
CMBM
CMBM
KMTS
KMTS
Q4 25
-113.5%
Q3 25
-177.8%
Q4 24
-26.8%
Q3 24
15.2%
Q2 24
0.2%
Q1 24
-37.0%
Q4 23
-14.0%
Q3 23
-3.3%
Capex Intensity
CMBM
CMBM
KMTS
KMTS
Q4 25
32.2%
Q3 25
42.2%
Q4 24
1.1%
Q3 24
4.8%
Q2 24
5.1%
Q1 24
3.3%
Q4 23
3.1%
Q3 23
2.5%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CMBM
CMBM

Enterprise$16.6M41%
Point To Multi Point$16.4M41%
Other$5.8M14%

KMTS
KMTS

Segment breakdown not available.

Related Comparisons